Works matching IS 00126667 AND DT 2024 AND VI 84 AND IP 10


Results: 12
    1
    2

    Cefepime–Taniborbactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.

    Published in:
    Drugs, 2024, v. 84, n. 10, p. 1219, doi. 10.1007/s40265-024-02082-9
    By:
    • Zhanel, George G.;
    • Mansour, Celine;
    • Mikolayanko, Stacey;
    • Lawrence, Courtney K.;
    • Zelenitsky, Sheryl;
    • Ramirez, Danyel;
    • Schweizer, Frank;
    • Bay, Denice;
    • Adam, Heather;
    • Lagacé-Wiens, Philippe;
    • Walkty, Andrew;
    • Irfan, Neal;
    • Clark, Nina;
    • Nicolau, David;
    • Tascini, Carlo;
    • Karlowsky, James A.
    Publication type:
    Article
    3

    Vorasidenib: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 10, p. 1325, doi. 10.1007/s40265-024-02097-2
    By:
    • Lamb, Yvette N.
    Publication type:
    Article
    4
    5
    6

    Golidocitinib: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 10, p. 1319, doi. 10.1007/s40265-024-02089-2
    By:
    • Keam, Susan J.
    Publication type:
    Article
    7

    Donanemab: First Approval.

    Published in:
    Drugs, 2024, v. 84, n. 10, p. 1313, doi. 10.1007/s40265-024-02087-4
    By:
    • Kang, Connie
    Publication type:
    Article
    8
    9
    10

    Anticoagulation in Chronic Kidney Disease.

    Published in:
    Drugs, 2024, v. 84, n. 10, p. 1199, doi. 10.1007/s40265-024-02077-6
    By:
    • Montomoli, Marco;
    • Candía, Boris Gonzales;
    • Barrios, Adriana Acosta;
    • Bernat, Elisa Perez
    Publication type:
    Article
    11
    12